Project
GFT505-315
Aborted ยท 2017 until 2020
Stillhard Roman, Semela David
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2017
End Date
2020
Financing
Industry
Brief description/objective
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis